APO RESEARCH · REPORT
Wound Care Biologics
Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme based formulations, Biologic Skin Substitutes, xenografts and cell based biogens to promote wound healing.
Product & engineering
Understand the product.
Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme based formulations, Biologic Skin Substitutes, xenografts and cell based biogens to promote wound healing.
Wound care biologics are being frequently used to treat complex burn injuries in patients with the inadequate skin for grafting. Since then, wound care biologics have been established and used to treat the prevalent problem of most complex chronic wounds such as diabetic foot ulcer and venous leg ulcers.
Selected research
Industry Research
Wound Care Biologics Industry Research Report 2026
Market perspective
Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme based formulations, Biologic Skin Substitutes, xenografts and cell based biogens to promote wound healing.
Wound care biologics are being frequently used to treat complex burn injuries in patients with the inadequate skin for grafting. Since then, wound care biologics have been established and used to treat the prevalent problem of most complex chronic wounds such as diabetic foot ulcer and venous leg ulcers.
Global Wound Care Biologics key players include Smith and Nephew, Organogenesis, MiMedx, Integra, Osiris, etc. Global top five players hold a share about 35%.
Read the full market overview
North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, having a total share about 35 percent.
In terms of product, Biologic Skin Substitutes is the largest segment, with a share about 55%. And in terms of application, the largest application is Chronic Wounds, followed by Acute Wounds, Surgical Wounds.
Report Scope
This report quantifies the global Wound Care Biologics market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Wound Care Biologics.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Wound Care Biologics Market by Company
Smith and Nephew
Organogenesis
MiMedx
Integra
Osiris
Derma Sciences, Inc
Soluble Systems
Amnio Technology, LLC
Medline
Skye® Biologics
Alphatec Spine,Inc.
Pinnacle Transplant Technologies
Wound Care Biologics Segment by Type
Biologic Skin Substitutes
Enzyme Based Formulations
Growth Factors
Wound Care Biologics Segment by Application
Acute Wounds
Chronic Wounds
Surgical Wounds
Wound Care Biologics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Wound Care Biologics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Wound Care Biologics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Wound Care Biologics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Wound Care Biologics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Biologic Skin Substitutes
- Enzyme Based Formulations
- Growth Factors
Applications
- Acute Wounds
- Chronic Wounds
- Surgical Wounds
Companies covered
- Smith and Nephew
- Organogenesis
- MiMedx
- Integra
- Osiris
- Derma Sciences, Inc
- Soluble Systems
- Amnio Technology, LLC
- Medline
- Skye® Biologics
- Alphatec Spine,Inc.
- Pinnacle Transplant Technologies
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Wound Care Biologics by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Biologic Skin Substitutes
- 2.2.3 Enzyme Based Formulations
- 2.2.4 Growth Factors
- 2.3 Wound Care Biologics by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Acute Wounds
- 2.3.3 Chronic Wounds
- 2.3.4 Surgical Wounds
- 2.4 Assumptions and Limitations
3 Wound Care Biologics Breakdown Data by Type
- 3.1 Global Wound Care Biologics Historic Market Size by Type (2021-2026)
- 3.2 Global Wound Care Biologics Forecasted Market Size by Type (2027-2032)
4 Wound Care Biologics Breakdown Data by Application
- 4.1 Global Wound Care Biologics Historic Market Size by Application (2021-2026)
- 4.2 Global Wound Care Biologics Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Wound Care Biologics Market Perspective (2021-2032)
- 5.2 Global Wound Care Biologics Growth Trends by Region
- 5.2.1 Global Wound Care Biologics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Wound Care Biologics Historic Market Size by Region (2021-2026)
- 5.2.3 Wound Care Biologics Forecasted Market Size by Region (2027-2032)
- 5.3 Wound Care Biologics Market Dynamics
- 5.3.1 Wound Care Biologics Industry Trends
- 5.3.2 Wound Care Biologics Market Drivers
- 5.3.3 Wound Care Biologics Market Challenges
- 5.3.4 Wound Care Biologics Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Wound Care Biologics Players by Revenue
- 6.1.1 Global Top Wound Care Biologics Players by Revenue (2021-2026)
- 6.1.2 Global Wound Care Biologics Revenue Market Share by Players (2021-2026)
- 6.2 Global Wound Care Biologics Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Wound Care Biologics Head Office and Area Served
- 6.4 Global Wound Care Biologics Players, Product Type & Application
- 6.5 Global Wound Care Biologics Manufacturers Established Date
- 6.6 Global Wound Care Biologics Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Wound Care Biologics Market Size (2021-2032)
- 7.2 North America Wound Care Biologics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Wound Care Biologics Market Size by Country (2021-2026)
- 7.4 North America Wound Care Biologics Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Wound Care Biologics Market Size (2021-2032)
- 8.2 Europe Wound Care Biologics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Wound Care Biologics Market Size by Country (2021-2026)
- 8.4 Europe Wound Care Biologics Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Wound Care Biologics Market Size (2021-2032)
- 9.2 Asia-Pacific Wound Care Biologics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Wound Care Biologics Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Wound Care Biologics Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Wound Care Biologics Market Size (2021-2032)
- 10.2 South America Wound Care Biologics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Wound Care Biologics Market Size by Country (2021-2026)
- 10.4 South America Wound Care Biologics Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Wound Care Biologics Market Size (2021-2032)
- 11.2 Middle East & Africa Wound Care Biologics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Wound Care Biologics Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Wound Care Biologics Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Smith and Nephew
- 12.1.1 Smith and Nephew Company Information
- 12.1.2 Smith and Nephew Business Overview
- 12.1.3 Smith and Nephew Revenue in Wound Care Biologics Business (2021-2026)
- 12.1.4 Smith and Nephew Wound Care Biologics Product Portfolio
- 12.1.5 Smith and Nephew Recent Developments
- 12.2 Organogenesis
- 12.2.1 Organogenesis Company Information
- 12.2.2 Organogenesis Business Overview
- 12.2.3 Organogenesis Revenue in Wound Care Biologics Business (2021-2026)
- 12.2.4 Organogenesis Wound Care Biologics Product Portfolio
- 12.2.5 Organogenesis Recent Developments
- 12.3 MiMedx
- 12.3.1 MiMedx Company Information
- 12.3.2 MiMedx Business Overview
- 12.3.3 MiMedx Revenue in Wound Care Biologics Business (2021-2026)
- 12.3.4 MiMedx Wound Care Biologics Product Portfolio
- 12.3.5 MiMedx Recent Developments
- 12.4 Integra
- 12.4.1 Integra Company Information
- 12.4.2 Integra Business Overview
- 12.4.3 Integra Revenue in Wound Care Biologics Business (2021-2026)
- 12.4.4 Integra Wound Care Biologics Product Portfolio
- 12.4.5 Integra Recent Developments
- 12.5 Osiris
- 12.5.1 Osiris Company Information
- 12.5.2 Osiris Business Overview
- 12.5.3 Osiris Revenue in Wound Care Biologics Business (2021-2026)
- 12.5.4 Osiris Wound Care Biologics Product Portfolio
- 12.5.5 Osiris Recent Developments
- 12.6 Derma Sciences, Inc
- 12.6.1 Derma Sciences, Inc Company Information
- 12.6.2 Derma Sciences, Inc Business Overview
- 12.6.3 Derma Sciences, Inc Revenue in Wound Care Biologics Business (2021-2026)
- 12.6.4 Derma Sciences, Inc Wound Care Biologics Product Portfolio
- 12.6.5 Derma Sciences, Inc Recent Developments
- 12.7 Soluble Systems
- 12.7.1 Soluble Systems Company Information
- 12.7.2 Soluble Systems Business Overview
- 12.7.3 Soluble Systems Revenue in Wound Care Biologics Business (2021-2026)
- 12.7.4 Soluble Systems Wound Care Biologics Product Portfolio
- 12.7.5 Soluble Systems Recent Developments
- 12.8 Amnio Technology, LLC
- 12.8.1 Amnio Technology, LLC Company Information
- 12.8.2 Amnio Technology, LLC Business Overview
- 12.8.3 Amnio Technology, LLC Revenue in Wound Care Biologics Business (2021-2026)
- 12.8.4 Amnio Technology, LLC Wound Care Biologics Product Portfolio
- 12.8.5 Amnio Technology, LLC Recent Developments
- 12.9 Medline
- 12.9.1 Medline Company Information
- 12.9.2 Medline Business Overview
- 12.9.3 Medline Revenue in Wound Care Biologics Business (2021-2026)
- 12.9.4 Medline Wound Care Biologics Product Portfolio
- 12.9.5 Medline Recent Developments
- 12.10 Skye® Biologics
- 12.10.1 Skye® Biologics Company Information
- 12.10.2 Skye® Biologics Business Overview
- 12.10.3 Skye® Biologics Revenue in Wound Care Biologics Business (2021-2026)
- 12.10.4 Skye® Biologics Wound Care Biologics Product Portfolio
- 12.10.5 Skye® Biologics Recent Developments
- 12.11 Alphatec Spine,Inc.
- 12.11.1 Alphatec Spine,Inc. Company Information
- 12.11.2 Alphatec Spine,Inc. Business Overview
- 12.11.3 Alphatec Spine,Inc. Revenue in Wound Care Biologics Business (2021-2026)
- 12.11.4 Alphatec Spine,Inc. Wound Care Biologics Product Portfolio
- 12.11.5 Alphatec Spine,Inc. Recent Developments
- 12.12 Pinnacle Transplant Technologies
- 12.12.1 Pinnacle Transplant Technologies Company Information
- 12.12.2 Pinnacle Transplant Technologies Business Overview
- 12.12.3 Pinnacle Transplant Technologies Revenue in Wound Care Biologics Business (2021-2026)
- 12.12.4 Pinnacle Transplant Technologies Wound Care Biologics Product Portfolio
- 12.12.5 Pinnacle Transplant Technologies Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst